FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masahiro Tabata

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Tumor Cells, Cultured

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Katsuyuki Hotta; Eiki Ichihara; Paolo Chiodini; Massimo Di Maio; Yoshiro Fujiwara; Akiko Hisamoto-Sato; Christian Manegold; Lothar Pilz; Martin Reck; Frances A Shepherd; Etsuji Suzuki; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Katsuyuki Kiura
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer.
Masanori Fujii; Akiko Hisamoto; Katsuyuki Hotta; Eiki Ichihara; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Katsuyuki Kiura
Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
Naoyuki Nogami; Masahiro Osawa; Isao Oze; Yoshihiko Segawa; Takuo Shibayama; Masahiro Tabata; Atsuhiko Tada; Saburo Takata; Nagio Takigawa; Akihiko Tamaoki; Mitsune Tanimoto; Masatoshi Uno; Masanori Fujii; Noboru Hamada; Shinobu Hosokawa; Katsuyuki Hotta; Eiki Ichihara; Genyo Ikeda; Shoichi Kuyama; Katsuyuki Kiura
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masahiro Tabata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katsuyuki Hotta; Eiki Ichihara; Paolo Chiodini; Massimo Di Maio; Yoshiro Fujiwara; Akiko Hisamoto-Sato; Christian Manegold; Lothar Pilz; Martin Reck; Frances A Shepherd; Etsuji Suzuki; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Katsuyuki Kiura
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2013;79(1):20-6.
2012: Masanori Fujii; Akiko Hisamoto; Katsuyuki Hotta; Eiki Ichihara; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Katsuyuki Kiura
Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
Lung cancer (Amsterdam, Netherlands) 2012;78(1):107-11.
2012: Naoyuki Nogami; Masahiro Osawa; Isao Oze; Yoshihiko Segawa; Takuo Shibayama; Masahiro Tabata; Atsuhiko Tada; Saburo Takata; Nagio Takigawa; Akihiko Tamaoki; Mitsune Tanimoto; Masatoshi Uno; Masanori Fujii; Noboru Hamada; Shinobu Hosokawa; Katsuyuki Hotta; Eiki Ichihara; Genyo Ikeda; Shoichi Kuyama; Katsuyuki Kiura
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.
Acta oncologica (Stockholm, Sweden) 2012;51(6):768-73.
2012: Kenichiro Kudo; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Yasushi Tanimoto; Akiko Hisamoto; Katsuyuki Hotta; Eiki Ichihara; Koichi Ichimura; Katsuyuki Kiura
[Case report: Two cases of adult Langerhans cell histiocytosis treated with systemic chemotherapy].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2012;101(5):1386-8.
2012: Nobuaki Ochi; Isao Oze; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Yoshiro Fujiwara; Akiko Hisamoto; Katsuyuki Hotta; Eiki Ichihara; Katsuyuki Kiura
Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades.
PloS one 2012;7(8):e42798.
2012: Saeko Ozaki; Isao Oze; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto; Soichiro Fushimi; Katsuyuki Hotta; Eiki Ichihara; Etsuko Kurimoto; Tetsuya Ogino; Katsuyuki Kiura
Favorable response of heavily treated Wilms' tumor to paclitaxel and carboplatin.
Onkologie 2012;35(5):283-6.
2011: Naoyuki Nogami; Takuo Shibayama; Tetsu Shinkai; Masahiro Tabata; Nagio Takigawa; Akihiko Tamaoki; Kenichi Chikamori; Shingo Harita; Shinobu Hosokawa; Katsuyuki Hotta; Daizo Kishino; Katsuyuki Kiura; Shoichi Kuyama; Hiroshi Ueoka; Mitsune Tanimoto
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.
Lung cancer (Amsterdam, Netherlands) 2011;74(1):80-4.
2011: Nagio Takigawa; A Tamaoki; Yoshiyuki Tokuda; Hiroshi Ueoka; Kazuhiko Watanabe; Kenichi Gemba; Naokatsu Horita; Katsuyuki Hotta; Susumu Kanazawa; Katsuyuki Kiura; Keitaro Matsuo; Tomonori Moritaka; Takuya Nagata; Niro Okimoto; Yoshihiko Segawa; Tetsu Shinkai; Masahiro Tabata; Hiromasa Takeda; Mitsuhiro Takemoto; Mitsune Tanimoto
Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(6):1087-91.
2011: Yoshiro Fujiwara; Katsuyuki Hotta; M Di Maio; Katsuyuki Kiura; Nagio Takigawa; Masahiro Tabata; Mitsune Tanimoto
Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(2):376-82.
2011: Katsuyuki Hotta; Eiki Ichihara; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Yoshiro Fujiwara; Akiko Hisamoto; Mitsune Tanimoto
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
PloS one 2011;6(11):e26646.
2011: Nagio Takigawa; Katsuyuki Kiura; Katsuyuki Hotta; Shinobu Hosokawa; Naoyuki Nogami; Keisuke Aoe; Kenichi Gemba; Keiichi Fujiwara; Shingo Harita; Mitsuhiro Takemoto; Kengo Himei; Tetsu Shinkai; Yoshirou Fujiwara; Saburo Takata; Masahiro Tabata; Susumu Kanazawa; Mitsune Tanimoto
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011;71(1):60-4.
2010: Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Etsuji Suzuki; Hiroshige Yoshioka; Toshiaki Okada; Daizo Kishino; Hiroshi Ueoka; Koji Inoue; Masahiro Tabata; Mitsune Tanimoto
Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
Lung cancer (Amsterdam, Netherlands) 2010;70(3):308-12.
2010: Yoshihiko Segawa; Katsuyuki Kiura; Katsuyuki Hotta; Nagio Takigawa; Masahiro Tabata; Keitaro Matsuo; Hiroshige Yoshioka; Hidetoshi Hayashi; Haruyuki Kawai; Keisuke Aoe; Tadashi Maeda; Hiroshi Ueoka; Mitsune Tanimoto
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(9):1430-4.
2010: Yoshihiko Segawa; Katsuyuki Kiura; Nagio Takigawa; Haruhito Kamei; Shingo Harita; Shunkichi Hiraki; Y Watanabe; Keisuke Sugimoto; Takuo Shibayama; Toshiro Yonei; Hiroshi Ueoka; Mitsuhiro Takemoto; Susumu Kanazawa; Ichiro Takata; Naoyuki Nogami; Katsuyuki Hotta; Akio Hiraki; Masahiro Tabata; Keitaro Matsuo; Mitsune Tanimoto
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3299-306.
2010: Daisuke Nojima; Katsuyuki Kiura; Katsuyuki Hotta; Nagio Takigawa; Masahiro Tabata; Mitsune Tanimoto
[Large cell neuroendocrine carcinoma of the mediastinum].
Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society 2010;48(7):506-10.
2010: Nobukazu Fujimoto; Katsuyuki Kiura; Nagio Takigawa; Yoshiro Fujiwara; Shinichi Toyooka; Shigeki Umemura; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer.
Acta medica Okayama 2010;64(1):33-7.
2010: Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Hiroshige Yoshioka; Shingo Harita; Shoichi Kuyama; Toshiro Yonei; Keiichi Fujiwara; Tadashi Maeda; Keisuke Aoe; Hiroshi Ueoka; Haruhito Kamei; Shigeki Umemura; Tomonori Moritaka; Yoshihiko Segawa; Haruyuki Kawai; Akihiro Bessho; Katsuya Kato; Masahiro Tabata; Mitsune Tanimoto
Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(2):179-84.
2009: Katsuyuki Hotta; Katsuyuki Kiura; Yoshiro Fujiwara; Nagio Takigawa; I Oze; N Ochi; Masahiro Tabata; Mitsune Tanimoto
Association between incremental gains in the objective response rate and survival improvement in phase III trials of first-line chemotherapy for extensive disease small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(5):829-34.
2009: Isao Oze; Katsuyuki Hotta; Katsuyuki Kiura; Nobuaki Ochi; Nagio Takigawa; Yoshiro Fujiwara; Masahiro Tabata; Mitsune Tanimoto
Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results.
PloS one 2009;4(11):e7835.
2009: Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Shoichi Kuyama; Yoshihiko Segawa; Toshiro Yonei; Kenichi Gemba; Keisuke Aoe; Takuo Shibayama; Keisuke Matsuo; Haruhito Kamei; Yoshiro Fujiwara; Akihiko Bessho; Tomonori Moritaka; Keisuke Sugimoto; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience.
Journal of cancer research and clinical oncology 2009;135(1):117-23.
2008: Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Yoshiro Fujiwara; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2008;62(2):236-41.
2008: Shigeki Umemura; Nobukazu Fujimoto; Akio Hiraki; Kenichi Gemba; Nagio Takigawa; Keiichi Fujiwara; Masanori Fujii; Hiroshi Umemura; Mamoru Satoh; Masahiro Tabata; Hiroshi Ueoka; Katsuyuki Kiura; Takumi Kishimoto; Mitsune Tanimoto
Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Carcinogenesis 2008;29(9):1845-9.
2008: Shoichi Kuyama; Katsuyuki Hotta; Masahiro Tabata; Yoshihiko Segawa; Yoshiro Fujiwara; Nagio Takigawa; Katsuyuki Kiura; Hiroshi Ueoka; Kenji Eguchi; Mitsune Tanimoto
Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):477-82.
2008: Yoshiro Fujiwara; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Katsuyuki Hotta; Shigeki Umemura; Masako Omori; Kenichi Gemba; Hiroshi Ueoka; Mitsune Tanimoto
Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine.
Anti-cancer drugs 2008;19(4):431-3.
2008: Yoshiro Fujiwara; Katsuyuki Kiura; Shinichi Toyooka; Katsuyuki Hotta; Masahiro Tabata; Nagio Takigawa; Junichi Soh; Yasushi Tanimoto; Arihiko Kanehiro; Katsuya Kato; Hiroshi Date; Mitsune Tanimoto
Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.
Lung cancer (Amsterdam, Netherlands) 2008;59(1):81-7.
2007: Toshio Kubo; Nagio Takigawa; Yasushi Tanimoto; Eiki Ichihara; Masahiro Tabata; Nobuaki Miyahara; Arihiko Kanehiro; Katsuyuki Kiura; Mitsune Tanimoto
[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].
Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society 2007;45(10):808-11.
2007: Akiko Hisamoto; Eisei Kondo; Katsuyuki Kiura; Toshiaki Okada; Shinobu Hosokawa; Junko Mimoto; Nagio Takigawa; Masahiro Tabata; Mitsune Tanimoto
Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice.
Lung cancer (Amsterdam, Netherlands) 2007;58(1):15-20.
2007: Toshiyuki Kozuki; Akiko Hisamoto; Masahiro Tabata; Nagio Takigawa; Katsuyuki Kiura; Yoshihiko Segawa; Masao Nakata; Koichi Mandai; Kenji Eguchi; Hiroshi Ueoka; Mitsune Tanimoto
Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
Lung cancer (Amsterdam, Netherlands) 2007;58(1):30-5.
2007: Masahiro Osawa; Nagio Takigawa; Katsuyuki Kiura; Kouichi Ichimura; Junji Matsuoka; Katsuyuki Hotta; Masahiro Tabata; Mitsune Tanimoto
Isolated metastasis of lung cancer to the thyroid gland.
Lung cancer (Amsterdam, Netherlands) 2007;58(1):156-8.
2007: Masanori Fujii; Katsuyuki Kiura; Nagio Takigawa; Tetsuya Yumoto; Yoshihide Sehara; Masahiro Tabata; Mitsune Tanimoto
Presentation of Garcin syndrome due to lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(9):877-8.
2007: Kadoaki Ohashi; Katsuyuki Kiura; Nagio Takigawa; Shigeki Umemura; Naruhito Kondo; Mistuhiro Takemoto; Kensuke Onoda; Motoi Aoe; Masahiro Tabata; Mistune Tanimoto
Radiation necrosis mimicking progressive brain metastasis in a patient with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(8):762-3.
2007: Shigeki Umemura; Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Masahiro Tabata; Akihiro Bessho; Tetsu Shinkai; Mitsune Tanimoto
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer.
Journal of cancer research and clinical oncology 2007;133(8):519-24.
2007: Katsuyuki Hotta; Katsuyuki Kiura; Shinichi Toyooka; Nagio Takigawa; Junichi Soh; Yoshiro Fujiwara; Masahiro Tabata; Hiroshi Date; Mitsune Tanimoto
Clinical significance of epidermal growth factor receptor gene mutations on treatment outcome after first-line cytotoxic chemotherapy in Japanese patients with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(7):632-7.
2007: Masahiro Tabata; Katsuyuki Kiura; Niro Okimoto; Yoshihiko Segawa; Tetsu Shinkai; Toshiro Yonei; Shoichi Kuyama; Shingo Harita; Katsuyuki Hotta; Hiroshi Ueoka; Mitsune Tanimoto
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
Cancer chemotherapy and pharmacology 2007;60(1):1-6.
2007: Masahiro Tabata; Toshiyuki Kozuki; Hiroshi Ueoka; Katsuyuki Kiura; Shingo Harita; Atsuhiko Tada; Takuo Shibayama; Nagio Takigawa; Toshiro Yonei; Kenichi Gemba; Yoshihiko Segawa; Daizo Kishino; Shinya Tada; Shunkichi Hiraki; Mitsune Tanimoto
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Cancer chemotherapy and pharmacology 2007;60(1):53-9.
2007: Katsuyuki Hotta; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Yoshiro Fujiwara; Shigeki Umemura; Mitsune Tanimoto
Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in Japanese patients with non-small cell lung cancer.
Anticancer research 2007;27(3B):1737-41.
2007: Katsuyuki Hotta; Yoshiro Fujiwara; Katsuyuki Kiura; Nagio Takigawa; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Relationship between response and survival in more than 50,000 patients with advanced non-small cell lung cancer treated with systemic chemotherapy in 143 phase III trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5):402-7.
2007: Nagio Takigawa; Masami Takeyama; Toshiyuki Kozuki; Takuo Shibayama; Akiko Hisamoto; Katsuyuki Kiura; Atsuhiko Tada; Katsuyuki Hotta; Shigeki Umemura; Kadoaki Ohashi; Yoshiro Fujiwara; Saburo Takata; Eiki Ichihara; Masahiro Osawa; Masahiro Tabata; Mitsune Tanimoto; Kiyoshi Takahashi
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells.
Oncology reports 2007;17(5):983-7.
2007: Katsuyuki Hotta; Yoshiro Fujiwara; Keitaro Matsuo; Takeshi Suzuki; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Hiroshi Ueoka; Mitsune Tanimoto
Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
Cancer 2007;109(5):939-48.
2007: Akiko Uchida; Seiki Hirano; Hiroyuki Kitao; Atsuko Ogino; Kanmei Rai; Shinichi Toyooka; Nagio Takigawa; Masahiro Tabata; Minoru Takata; Katsuyuki Kiura; Mitsune Tanimoto
Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation.
Cancer science 2007;98(3):357-63.
2007: Yoshiro Fujiwara; Katsuyuki Kiura; Katsuyuki Hotta; Masahiro Tabata; Nagio Takigawa; Mitsune Tanimoto
Being overweight influences the development of hepatic dysfunction in Japanese patients with non-small-cell lung cancer undergoing cytotoxic chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2007;55(3):343-8.
2007: Katsuyuki Hotta; Masahiro Tabata; Katsuyuki Kiura; Toshiyuki Kozuki; Akiko Hisamoto; Hideki Katayama; Nagio Takigawa; Nobukazu Fujimoto; Keiichi Fujiwara; Hiroshi Ueoka; Mitsune Tanimoto
Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.
Oncology reports 2007;17(2):313-7.
2007: Katsuyuki Kiura; Nagio Takigawa; Yoshihiko Segawa; Masahiro Tabata; Takuo Shibayama; Kenichi Gemba; Akihiro Bessho; Nobukazu Fujimoto; Ichiro Takata; Katsuyuki Hotta; Keiichi Fujiwara; Yoshiyuki Tokuda; Shoichi Kuyama; Tetsu Shinkai; Hiroshi Ueoka; Mitsune Tanimoto
Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(1):44-50.
2006: Nagio Takigawa; Katsuyuki Kiura; Yoshihiko Segawa; Y Watanabe; Haruhito Kamei; Tomonori Moritaka; Takuo Shibayama; Hiroshi Ueoka; Kenichi Gemba; Toshiro Yonei; Masahiro Tabata; Tetsu Shinkai; Shunkichi Hiraki; Mitsuhiro Takemoto; S Kanazawa; Kiyoshi Matsuo; Mitsune Tanimoto
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer.
British journal of cancer 2006;95(9):1142-4.
2006: Kadoaki Ohashi; Katsuyuki Kiura; Nagio Takigawa; Takaaki Mizushima; Hideo Ino; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine.
Anticancer research 2006;26(6C):4695-6.
2006: Noriyuki Suzaki; Akio Hiraki; Nagio Takigawa; Hiroshi Ueoka; Yasushi Tanimoto; Toshiyuki Kozuki; Masahiro Tabata; Arihiko Kanehiro; Katsuyuki Kiura; Mitsune Tanimoto
Severe interstitial pneumonia induced by paclitaxel in a patient with adenocarcinoma of the lung.
Acta medica Okayama 2006;60(5):295-8.
2006: Takuo Shibayama; Katsuyuki Hotta; Nagio Takigawa; Atsuhiko Tada; Hiroshi Ueoka; Shingo Harita; Katsuyuki Kiura; Masahiro Tabata; Yoshihiko Segawa; Naoyuki Nogami; Shoichi Kuyama; Tetsu Shinkai; Mitsune Tanimoto
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(2):189-95.
2006: Masaki Tokumo; Shinichi Toyooka; Shuji Ichihara; Kadoaki Ohashi; Kazunori Tsukuda; Kouichi Ichimura; Masahiro Tabata; Katsuyuki Kiura; Motoi Aoe; Yoshifumi Sano; Hiroshi Date; Nobuyoshi Shimizu
Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):117-21.
2006: Takuji Kitajima; Kenji Nishii; Hiroshi Ueoka; Takuo Shibayama; Kenichi Gemba; Tsuyoshi Kodani; Katsuyuki Kiura; Masahiro Tabata; Katsuyuki Hotta; Mitsune Tanimoto; Tomotaka Sobue
Recent improvement in lung cancer screening: a comparison of the results carried out in two different time periods.
Acta medica Okayama 2006;60(3):173-9.
2006: Keiichi Fujiwara; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Katsuyuki Hotta; Shigeki Umemura; Keisuke Sugimoto; Takuo Shibayama; Haruhito Kamei; Shingo Harita; Niro Okimoto; Mitsune Tanimoto
A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer.
Cancer chemotherapy and pharmacology 2006;57(6):755-60.
2006: Nagio Takigawa; Masako Takeyama; Takuo Shibayama; Atsuhiko Tada; Noriko Kawata; Chiharu Okada; Keisuke Aoe; Toshiyuki Kozuki; Katsuyuki Hotta; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto; Kiyoshi Takahashi
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells.
Oncology reports 2006;15(4):837-42.
2006: Yoshiro Fujiwara; Katsuyuki Kiura; Shinichi Toyooka; Nagio Takigawa; Masaki Tokumo; Katsuyuki Hotta; Motoi Aoe; Masahiro Tabata; Keitaro Matsuo; Hiroshi Date; Mitsune Tanimoto
Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;52(1):99-103.
2006: Shingo Harita; Youichi Watanabe; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Shoichi Kuyama; Toshiyuki Kozuki; Haruhito Kamei; Atsuhiko Tada; Niro Okimoto; Kenichi Genba; Shinichi Tada; Hiroshi Ueoka; Shunkichi Hiraki; Mitsune Tanimoto
Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer.
Anticancer research 2006;26(2B):1637-41.
2005: Katsuyuki Hotta; Kiyoshi Matsuo; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Shingo Harita; Kenichi Gemba; Toshiro Yonei; Akihiro Bessho; Mitsune Tanimoto
Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1817-23.
2005: Katsuyuki Hotta; Katsuyuki Kiura; Masahiro Tabata; Shingo Harita; Kenichi Gemba; Toshiro Yonei; Akihiro Bessho; Tadashi Maeda; Tomonori Moritaka; Takuo Shibayama; Keitaro Matsuo; Katsuya Kato; Arihiko Kanehiro; Yasushi Tanimoto; Keitaro Matsuo; Hiroshi Ueoka; Mitsune Tanimoto
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.
Cancer journal (Sudbury, Mass.) 2005;11(5):417-24.
2005: Shigeki Umemura; Daizo Kishino; Masahiro Tabata; Katsuyuki Kiura; Katsuyuki Hotta; Kenji Nishii; Yasushi Tanimoto; Arihiko Kanehiro; Kenji Notohara; Hiroshi Ueoka; Mitsune Tanimoto
Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer.
Internal medicine (Tokyo, Japan) 2005;44(9):979-82.
2005: Keisuke Aoe; Akio Hiraki; Tadashi Maeda; Hideki Katayama; Keiichi Fujiwara; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto
Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.
Internal medicine (Tokyo, Japan) 2005;44(8):800-4.
2005: Tadashi Matsumura; Nagio Takigawa; Katsuyuki Kiura; Takuo Shibayama; Masakazu Chikamori; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity.
In vivo (Athens, Greece) 2005;19(4):717-21.
2005: Akiko Uchida; Masahiro Tabata; Katsuyuki Kiura; Yasushi Tanimoto; Arihiko Kanehiro; Motoi Aoe; Nobuya Ohohara; Hiroshi Ueoka; Mitsune Tanimoto
Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin.
Japanese journal of clinical oncology 2005;35(7):417-9.
2005: Katsuyuki Hotta; Nagio Takigawa; Katsuyuki Kiura; Masahiro Tabata; Shigeki Umemura; Atsuko Ogino; Akiko Uchida; Akihiro Bessho; Yoshihiko Segawa; Tetsu Shinkai; Naoyuki Nogami; Shingo Harita; Niro Okimoto; Hiroshi Ueoka; Mitsune Tanimoto
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.
Anticancer research 2005;25(3c):2429-34.
2005: Toshiyuki Kozuki; Nobukazu Fujimoto; Hiroshi Ueoka; Katsuyuki Kiura; Keiichi Fujiwara; Katsuhiko Shiomi; Koichi Mizobuchi; Masahiro Tabata; Shuji Hamazaki; Mitsune Tanimoto
Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
Journal of cancer research and clinical oncology 2005;131(3):147-51.
2005: Keiichi Fujiwara; Nobukazu Fujimoto; Masahiro Tabata; Kenji Nishii; Keitaro Matsuo; Katsuyuki Hotta; Toshiyuki Kozuki; Motoi Aoe; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto
Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1219-25.
2005: Masaki Tokumo; Shinichi Toyooka; Katsuyuki Kiura; Hisayuki Shigematsu; Kunitoshi Tomii; Motoi Aoe; Kouichi Ichimura; Toshihide Tsuda; Masaaki Yano; Kazunori Tsukuda; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto; Hiroshi Date; Adi F Gazdar; Nobuyoshi Shimizu
The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1167-73.
2005: Katsuyuki Hotta; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Atsuko Ogino; Shigeki Umemura; Shingo Harita; Kenichi Gemba; Toshiro Yonei; Akihiro Bessho; Tadashi Maeda; Mitsune Tanimoto
Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience.
Acta oncologica (Stockholm, Sweden) 2005;44(7):717-22.
2005: Keiichi Fujiwara; Katsuyuki Kiura; Kenichi Gemba; Yoshiko Ogata; Katsuyuki Hotta; Daizo Kishino; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto
Gefitinib ('Iressa', ZD1839) may restore chemosensitivity in NSCLC patients?
Anticancer research 2005;25(1B):547-9.
2004: Katsuyuki Hotta; Kiyoshi Matsuo; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Mitsune Tanimoto
Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1782-9.
2004: Masakazu Chikamori; Nagio Takigawa; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; Yoshihiko Segawa; Hiroshi Ueoka; Taisuke Ohnoshi; Mitsune Tanimoto
Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line.
Anticancer research 2004;24(6):3911-6.
2004: Keisuke Aoe; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; Masakazu Chikamori; Hiroyuki Kohara; Mine Harada; Mitsune Tanimoto
Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines.
Anticancer research 2004;24(6):3893-7.
2004: Katsuyuki Hotta; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; Keiichi Fujiwara; Toshiyuki Kozuki; Toshiaki Okada; Akiko Hisamoto; Mitsune Tanimoto
Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46(2):255-61.
2004: Katsuyuki Hotta; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Mitsune Tanimoto
An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;46(1):61-76.
2004: Katsuyuki Hotta; Keitaro Matsuo; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Mitsune Tanimoto
Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3852-9.
2004: Katsuyuki Hotta; Keitaro Matsuo; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Mitsune Tanimoto
Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3860-7.
2004: Nagio Takigawa; Yoshihiko Segawa; Daizo Kishino; Keiichi Fujiwara; Yoshiyuki Tokuda; Nobuhiko Seki; Tetsu Shinkai; Yoichi Watanabe; Shunkichi Hiraki; Toshiyuki Kozuki; Kenichi Gemba; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
Cancer chemotherapy and pharmacology 2004;54(3):230-6.
2004: Naoyuki Nogami; Shingo Harita; Hiroshi Ueoka; Toshiro Yonei; Katsuyuki Kiura; Haruhito Kamei; Masahiro Tabata; Yoshihiko Segawa; Kenichi Gemba; Mitsune Tanimoto
Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;45(1):85-91.
2004: Katsuyuki Hotta; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Shoichi Kuyama; Ken Satoh; Toshiyuki Kozuki; Akiko Hisamoto; Shinobu Hosokawa; Keiichi Fujiwara; Mitsune Tanimoto
A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;45(1):77-84.
2004: H Katayama; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; T Kozuki; Mitsune Tanimoto; T Fujiwara; N Tanaka; H Date; M Aoe; N Shimizu; M Takemoto; Y Hiraki
Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer.
British journal of cancer 2004;90(5):979-84.
2004: Keisuke Aoe; Akio Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Motoyuki Tanaka; Mitsune Tanimoto
Thrombocytosis as a useful prognostic indicator in patients with lung cancer.
Respiration; international review of thoracic diseases 2004;71(2):170-3.
2004: Toshiyuki Kozuki; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; Hiroshi Date; Shuji Hamazaki; Akihiro Bessho; Mitsune Tanimoto
Long-term effect of gefitinib (ZD1839) on squamous cell carcinoma of the lung.
Anticancer research 2004;24(1):393-6.
2003: Katsuyuki Hotta; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Eisei Kondoh; Yoshihiko Segawa; Hiroshi Date; Nobuyoshi Shimizu; Tadashi Yoshino; Mine Harada; Mitsune Tanimoto
Successful treatment of limited disease-small cell lung cancer with multimodality treatment consisting of concurrent chemoradiotherapy, high-dose chemotherapy with autologous peripheral blood stem cell transplantation and surgical resection.
Internal medicine (Tokyo, Japan) 2003;42(12):1223-7.
2003: Masashi Kawaraya; Kenichi Gemba; Hiroshi Ueoka; Kenji Nishii; Katsuyuki Kiura; Tsuyoshi Kodani; Masahiro Tabata; Takuo Shibayama; Takuji Kitajima; Mitsune Tanimoto
Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer.
British journal of cancer 2003;89(10):1885-8.
2003: Nobukazu Fujimoto; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Akihiro Bessho; Ichiro Takata; Kazutaka Sunami; Yasushi Hiramatsu; Kazuma Ikeda; Mitsune Tanimoto; Mine Harada
Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.
Anticancer research 2003;23(5b):4229-32.
2003: Katsuyuki Kiura; Hiroshi Ueoka; Yoshihiko Segawa; Masahiro Tabata; Haruhito Kamei; Nagio Takigawa; Shunkichi Hiraki; Y Watanabe; Akihiro Bessho; Kenji Eguchi; Niro Okimoto; Shingo Harita; Mitsuhiro Takemoto; Yoshio Hiraki; Mine Harada; Mitsune Tanimoto
Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer.
British journal of cancer 2003;89(5):795-802.
2003: Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Yoshio Hiraki; Yoichi Watanabe; Toshiro Yonei; Tomonori Moritaka; Junichiro Hiyama; Shunkichi Hiraki; Mitsune Tanimoto; Mine Harada
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):13-20.
2003: Akio Hiraki; Hiroshi Ueoka; Kenichi Gemba; Shoichi Kuyama; Daizo Kishino; Masahiro Tabata; Katsuyuki Kiura; Mitsune Tanimoto; Mine Harada
Hydronephrosis as a complication of adenocarcinoma of the lung.
Anticancer research 2003;23(3C):2915-6.
2003: Kazuyo Miyatake; Kenichi Gemba; Hiroshi Ueoka; Kenji Nishii; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; Nagio Takigawa; Masashi Kawaraya; Mitsune Tanimoto
Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
Anticancer research 2003;23(3C):2829-36.
2003: Keiichi Fujiwara; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; Shuji Hamasaki; Mitsune Tanimoto
Dramatic effect of ZD1839 ('Iressa') in a patient with advanced non-small-cell lung cancer and poor performance status.
Lung cancer (Amsterdam, Netherlands) 2003;40(1):73-6.
2003: Nagio Takigawa; Keiichi Fujiwara; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Akio Hiraki; Takuo Shibayama; Yoshihiko Segawa; Haruhito Kamei; Shunkichi Hiraki; Mitsune Tanimoto; Mine Harada
Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study.
Anticancer research 2003;23(1B):557-60.
2002: Noriko Namba; Akio Hiraki; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Tadashi Yoshino; Mitsune Tanimoto
Axillary metastasis as the first manifestation of occult breast cancer in a man: a case report.
Anticancer research 2002;22(6B):3611-3.
2002: Ichiro Takata; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Hideki Katayama; Mitsuhiro Takemoto; Yoshio Hiraki; Mine Harada; Mitsune Tanimoto
Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer.
Acta medica Okayama 2002;56(5):261-6.
2002: Kazuhiko Kawada; Toshiro Yonei; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Mine Harada; Mitsune Tanimoto
Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
Acta medica Okayama 2002;56(3):129-34.
2002: Tsuyoshi Kodani; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Yoshihiko Segawa; Tomonori Moritaka; Shunkichi Hiraki; Mine Harada; Mitsune Tanimoto
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Lung cancer (Amsterdam, Netherlands) 2002;36(3):313-9.
2002: Hiroshi Ueoka; Masahiro Tabata
[Combined modality treatment for non-small cell lung cancer].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 5():455-8.
2002: Atsuhiko Tada; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Mitsuhiro Takemoto; Hiromichi Yamane; Junichiro Hiyama; Keisuke Aoe; Takuo Shibayama; Haruhito Kamei; Shin Kawahara; Shingo Harita; Toshio Sato; Makoto Kobayashi; Kenji Eguchi; Shunkichi Hiraki; Yoshio Hiraki; Mitsune Tanimoto
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(5):751-6.
2002: Akio Hiraki; Hiroshi Ueoka; Tadashi Yoshino; Masahiro Tabata; Katsuyuki Kiura; Yasushi Tanimoto; Takayuki Kamao; Reiko Komoto; Mine Harada
Primary signet-ring cell carcinoma of the lung with histochemical characterization.
Anticancer research 2002;22(2B):1079-81.
2002: Akio Hiraki; Katsuyuki Kiura; Hiromichi Yamane; Naoyuki Nogami; Masahiro Tabata; Nagio Takigawa; Hiroshi Ueoka; Mitsune Tanimoto; Mine Harada
Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):329-33.
2002: Haruyuki Kawai; Katsuyuki Kiura; Masahiro Tabata; Tadashi Yoshino; Ichiro Takata; Akio Hiraki; Kenichi Chikamori; Hiroshi Ueoka; Mitsune Tanimoto; Mine Harada
Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):305-14.
2002: Seisuke Ota; Katsuji Shinagawa; Hiroshi Ueoka; Shinya Tada; Masahiro Tabata; Shuji Hamazaki; Eisaku Kondo; Katsuyuki Kiura; Tomohiko Mannami; Takuo Shibayama; Kenji Niiya; Mine Harada
Spontaneous regression of metastatic endometrial stromal sarcoma.
Japanese journal of clinical oncology 2002;32(2):71-4.
2002: Hiroyuki Kohara; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Kazuhiko Kawata; Masakazu Chikamori; Keisuke Aoe; Kenichi Chikamori; Akio Matsushita; Mine Harada
Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):287-92.
2001: Kenji Nishii; Hiroshi Ueoka; Katsuyuki Kiura; Tsuyoshi Kodani; Masahiro Tabata; Takuo Shibayama; Kenichi Gemba; Takuji Kitajima; Akio Hiraki; Masashi Kawaraya; T Nakayama; Mine Harada
A case-control study of lung cancer screening in Okayama Prefecture, Japan.
Lung cancer (Amsterdam, Netherlands) 2001;34(3):325-32.
2001: Hiroshi Ueoka; Mitsune Tanimoto; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigawa; Yoshihiko Segawa; Ichiro Takata; Kenji Eguchi; Niro Okimoto; Shingo Harita; Haruhito Kamei; Takuo Shibayama; Y Watanabe; Shunkichi Hiraki; Mine Harada
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group.
British journal of cancer 2001;85(1):9-13.
2000: T Maeda; Hiroshi Ueoka; Masahiro Tabata; Katsuyuki Kiura; Takuo Shibayama; Kenichi Gemba; Nagio Takigawa; Akio Hiraki; H Katayama; Mine Harada
Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.
Japanese journal of clinical oncology 2000;30(12):534-41.
2000: Kenichi Gemba; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Mine Harada
Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome.
Lung cancer (Amsterdam, Netherlands) 2000;29(1):23-31.
2000: Akihiro Bessho; Masahiro Tabata; Katsuyuki Kiura; Ichiro Takata; T Nagata; Nobukazu Fujimoto; K Kunisada; Hiroshi Ueoka; Mine Harada
Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction.
Anticancer research 2000;20(2B):1149-54.
2000: Nagio Takigawa; Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; Ichiro Takata; H Miyamoto; Kenji Eguchi; Mine Harada
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 2000;46(4):272-8.
2000: Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Kiura; Haruhito Kamei; Masahiro Tabata; K Sakae; Yoshio Hiraki; S Kawahara; Kenji Eguchi; Shunkichi Hiraki; Mine Harada
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
British journal of cancer 2000;82(1):104-11.
1999: Hiromichi Yamane; Akihiro Bessho; Katsuyuki Kiura; Masahiro Tabata; Y Katayama; K Motoda; T Tsuchida; Naoyuki Nogami; Akio Hiraki; Hiroshi Ueoka; Mine Harada
Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer.
Internal medicine (Tokyo, Japan) 1999;38(11):892-5.
1999: S Ikubo; Nagio Takigawa; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; Masakazu Chikamori; Keisuke Aoe; Akio Matsushita; Mine Harada
In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
Anticancer research 1999;19(5B):3985-8.
1999: Akio Matsushita; Masahiro Tabata; Hiroshi Ueoka; Katsuyuki Kiura; Takuo Shibayama; Keisuke Aoe; Hiroyuki Kohara; Mine Harada
Establishment of a drug sensitivity panel using human lung cancer cell lines.
Acta medica Okayama 1999;53(2):67-75.
1999: Hiroshi Ueoka; Masahiro Tabata; Katsuyuki Kiura; Takuo Shibayama; Kenichi Gemba; Yoshihiko Segawa; Kenichi Chikamori; Toshiro Yonei; Shunkichi Hiraki; Mine Harada
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study.
British journal of cancer 1999;79(5-6):984-90.
1999: Keisuke Aoe; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; T Matsumura; Masakazu Chikamori; Akio Matsushita; Hiroyuki Kohara; Mine Harada
Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.
Anticancer research 1999;19(1A):291-9.
1999: Akihiro Bessho; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Kazutaka Sunami; Y Katayama; H Yamane; Akio Hiraki; Mine Harada
High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Anticancer research 1999;19(1B):693-8.
1998: Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Haruhito Kamei; Kenichi Gemba; K Sakae; Yoshio Hiraki; Shunkichi Hiraki; Yoshihiko Segawa; Mine Harada
A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Cancer 1998;83(2):283-90.
1998: Katsuyuki Kiura; S Watarai; Hiroshi Ueoka; Masahiro Tabata; Kenichi Gemba; Keisuke Aoe; H Yamane; T Yasuda; Mine Harada
An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line.
Anticancer research 1998;18(4C):2957-60.
1998: M Tamura; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; K Miyatake; Kenichi Gemba; Shunkichi Hiraki; Mine Harada
Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials.
Acta medica Okayama 1998;52(2):105-11.
1998: Tomonori Moritaka; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; Yoshihiko Segawa; Takuo Shibayama; Nagio Takigawa; T Ohnoshi; Mine Harada
Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
Anticancer research 1998;18(2A):927-33.
1998: Akio Hiraki; Hiroshi Ueoka; Masahiro Tabata; Katsuyuki Kiura; Akihiro Bessho; Hiromichi Yamane; Naoyuki Nogami; Mine Harada
Spontaneous biloma as a complication of small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;19(2):127-30.
1997: Hiroyuki Kohara; Hiroshi Ueoka; Masahiro Tabata; Katsuji Shinagawa; K Hayashi; Mine Harada
High-dose etoposide treatment for CNS involvement in a patient with primary non-Hodgkin's lymphoma of the breast.
Internal medicine (Tokyo, Japan) 1997;36(10):738-41.
1997: Akio Hiraki; Masahiro Tabata; Hiroshi Ueoka; Katsuyuki Kiura; T Shibayama; H Yamane; Mine Harada
Direct intracerebral invasion from skull metastasis of large cell lung cancer.
Internal medicine (Tokyo, Japan) 1997;36(10):720-3.
1997: H Yamane; Katsuyuki Kiura; Masahiro Tabata; Akihiro Bessho; T Tsuchida; K Motoda; Akio Hiraki; Hiroshi Ueoka; Mine Harada
Small cell lung cancer can express CD34 antigen.
Anticancer research 1997;17(5A):3627-32.
1997: Kiyoshi Matsuo; Katsuyuki Kiura; Hiroshi Ueoka; Masahiro Tabata; Takuo Shibayama; T Matsumura; Nagio Takigawa; Shunkichi Hiraki; Mine Harada
Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line.
Acta medica Okayama 1997;51(3):121-7.
1996: Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Akihiro Bessho; A Matsushita; Kenichi Chikamori; H Yamane; Mine Harada; I Kimura; T Ohnoshi
[Chemotherapy for small-cell lung cancer].
Nihon Kyōbu Shikkan Gakkai zasshi 1996;34 Suppl():87-91.
1995: K Miyatake; Hiroshi Ueoka; Masahiro Tabata; Takuo Shibayama; Kenichi Gemba; J Hiyama; T Ohnoshi; Mine Harada; K Nishii; Y Moritani
[Gingival metastasis of large-cell lung cancer that produced G-CSF].
Nihon Kyōbu Shikkan Gakkai zasshi 1995;33(11):1283-7.
1995: Takuo Shibayama; J Hiyama; Hiroshi Ueoka; Masahiro Tabata; Yoshihiko Segawa; Kenichi Gemba; A Matsushita; T Ohnoshi; M Harada; A Andoh
[Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)].
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(13):1953-8.
1994: T Matsumura; T Ohnoshi; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; K Genba; Masakazu Chikamori; S Ikubo; K Matsuo; I Kimura
[Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(2):261-4.
1993: Hiroshi Ueoka; T Ohnoshi; Shunkichi Hiraki; H Kamei; Masahiro Tabata; Takuo Shibayama; K Miyatake; Kenichi Gemba; J Hiyama; I Kimura
[CAV-PVP chemotherapy and sequential thoracic irradiation (TI) for patients with limited (LD) small cell lung cancer (SCLC)].
Nihon Kyōbu Shikkan Gakkai zasshi 1993;31 Suppl():218-24.
1993: T Ohnoshi; Shunkichi Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; H Kamei; T Horiguchi; T Kodani; T Maeda; Masahiro Tabata; Takuo Shibayama
Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Cancer 1993;72(5):1597-601.
1993: Masahiro Tabata; T Ohnoshi; Hiroshi Ueoka; Katsuyuki Kiura; I Kimura
MDR1 gene expression and treatment outcome in small cell lung cancer: MDR1 gene expression as an independent prognostic factor.
Acta medica Okayama 1993;47(4):243-8.
1993: Toshiro Yonei; T Ohnoshi; Shunkichi Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; T Moritaka; Takuo Shibayama; Masahiro Tabata; Yoshihiko Segawa; Nagio Takigawa
Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
Acta medica Okayama 1993;47(4):233-41.
1993: Nagio Takigawa; T Ohnoshi; Hiroshi Ueoka; T Horiguchi; Katsuyuki Kiura; Masahiro Tabata; Yoshihiko Segawa; Takuo Shibayama; K Genba; T Matsumura
[Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(9):1221-6.
1993: Katsuyuki Kiura; T Ohnoshi; Masahiro Tabata; Takuo Shibayama; I Kimura
Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.
Acta medica Okayama 1993;47(3):191-7.
1993: Yoshihiko Segawa; T Ohnoshi; Shunkichi Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; H Kamei; Masahiro Tabata; Takuo Shibayama; K Miyatake; K Genba
Immunohistochemical detection of P-glycoprotein and carcinoembryonic antigen in small cell lung cancer: with reference to predictability of response to chemotherapy.
Acta medica Okayama 1993;47(3):181-9.
1993: Nagio Takigawa; T Ohnoshi; Hiroshi Ueoka; Toshiro Yonei; Katsuyuki Kiura; Masahiro Tabata; T Kodani; H Kamei; Yoshihiko Segawa; Takuo Shibayama
[Cytotoxic effect of topoisomerase II inhibitors against adriamycin- and etoposide-resistant small cell lung cancer sublines].
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(7):929-35.
1993: Nagio Takigawa; T Ohnoshi; Hiroshi Ueoka; Katsuyuki Kiura; Takuo Shibayama; Yoshihiko Segawa; Masahiro Tabata; T Maeda; K Miyatake; I Kimura
[A case of small cell bronchogenic carcinoma accompanied by polyneuropathy and SIADH].
Nihon Kyōbu Shikkan Gakkai zasshi 1993;31(3):346-51.
1993: Nagio Takigawa; T Ohnoshi; Hiroshi Ueoka; Katsuyuki Kiura; T Moritaka; Masahiro Tabata; Yoshihiko Segawa; Takuo Shibayama; Kenichi Gemba; T Matsumura
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(4):473-7.
1993: Masahiro Tabata; T Ohnoshi; Hiroshi Ueoka; Katsuyuki Kiura; Yoshihiko Segawa; Takuo Shibayama; T Maeda; K Miyatake; Nagio Takigawa; I Kimura
[A case of small cell lung cancer associated with diabetes insipidus and Cushing's syndrome].
Nihon Kyōbu Shikkan Gakkai zasshi 1993;31(2):235-9.
1992: Yoshihiko Segawa; T Ohnoshi; Hiroshi Ueoka; Katsuyuki Kiura; T Horiguchi; T Kodani; H Kamei; Masahiro Tabata; Takuo Shibayama; T Maeda
[A case of locally advanced esophageal cancer effectively treated with concurrent chemotherapy and radiotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(4):529-32.
1992: T Ohnoshi; Hiroshi Ueoka; Yoshihiko Segawa; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; T Maeda; K Miyatake; Nagio Takigawa; I Kimura
[Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy].
Nihon Kyōbu Shikkan Gakkai zasshi 1992;30(2):262-9.
1991: Hiroshi Ueoka; T Ohnoshi; T Moritaka; Katsuyuki Kiura; Y Mima; T Horiguchi; Yoshihiko Segawa; Masahiro Tabata; Takuo Shibayama; T Maeda
[A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Nihon Kyōbu Shikkan Gakkai zasshi 1991;29(8):1022-8.